Working memory impairment in a transgenic amyloid precursor protein TgCRND8 mouse model of Alzheimer's disease

Genes, Brain and Behavior

Volumn 4, Issue 3, 2005, Pages 197-208

  Lovasic, L ^a   Bauschke, H ^b   Janus, C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

APP; Memory; Radial water maze; Spatial navigation; Transgenic mouse

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FEMALE; GENE EXPRESSION; GENE MUTATION; LATENT PERIOD; LEARNING; MALE; MAZE TEST; MEMORY DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPATIAL MEMORY; TRANSGENIC MOUSE; WORKING MEMORY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MAZE LEARNING; MEMORY, SHORT-TERM; MICE; PROBLEM SOLVING; RANDOM ALLOCATION; SPATIAL BEHAVIOR; STATISTICS, NONPARAMETRIC;

EID: 17644412057     PISSN: 16011848     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2004.00104.x     Document Type: Article

References (60)

1. Albert, M.S. (1996) Cognitive and neurobiologic markers of early Alzheimer's disease. Proc Natl Acad Sci USA 93, 13547-13551.
2. Almkvist, O., Brane, G. & Johanson, A. (1996) Neuropsychological assessment of dementia: state of the art. Acta Neurol Scand Suppl 168, 45-49.
3. Arendash, G.W., King, D.L., Gordon, M.N., Morgan, D., Hatcher, J.M., Hope, C.E. & Diamond, D.M. (2001) Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res 891, 42-53.
4. Ashe, K.H. (2001) Learning and memory in transgenic mice modelling Alzhiemer's disease. Learn Mem 8, 301-308.
5. Austin, L., Arendash, G.W., Gordon, M.N., Diamond, D.M., DiCarlo, G., Dickey, C., Ugen, K. & Morgan, D. (2003) Short-term beta-amyloid vaccinations do not improve cognitive performance in cognitively impaired APP + PS1 mice. Behav Neurosci 117, 478-484.
6. Backman, L. & Small, B.J. (1998) Influences of cognitive support on episodic remembering: tracing the process of loss from normal aging to Alzheimer's disease. Psychol Aging 13, 267-276.
7. Berger-Sweeney, J., McPhie, D.L., Arters, J.A., Greenan, J., Oster-Granite, M.L. & Neve, R.L (1999) Impairments in learning and memory accompanied by neurodegeneration in mice transgenic for the carboxyl-terminus of the amyloid precursor protein. Brain Res Mol Brain Res 66, 150-162.
8. Bimonte, H.A., Hyde, L.A., Hoplight, B.J. & Denenberg, V.H. (2000) In two species, females exhibit superior working memory and inferior reference memory on the water radial-arm maze. Physiol Behav 70, 311-317.
9. Buresova, O., Bures, J., Oitzl, M.S. & Zahalka, A. (1985) Radial maze in the water tank: an aversively motivated spatial working memory task. Physiol Behav 34, 1003-1005.
10. Bush, A.I. (2001) Therapeutic targets in the biology of Alzheimer's disease. Curr Opin Psychiatry 14, 341-348.
11. Chapman, P.F., White, G.L., Jones, M.W., Cooper-Blacketer, D., Marshall, V.J., Irizarry, M., Younkin, L., Good, M.A., Bliss, T.V., Hyman, B.T., Younkin, S.G. & Hsiao, K.K. (1999) Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 2, 271-276.
12. Chen, G.Q., Chen, K.S., Knox, J., Inglis, J., Bernard, A., Martin, S.J., Justice, A., McConlogue, L., Games, D., Freedman, S.B. & Morris, R.G.M. (2000). A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 408, 975-979.
13. Chishti, M.A., Yang, D.S., Janus, C., Phinney, A.L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., Turner, S., Lozza, G., Grilli, M., Kunicki, S., Morissette, C., Paquette, J., Gervais, F., Bergeron, C., Fraser, P.E., Carlson, G.A., St George-Hyslop, P. & Westaway, D. (2001) Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 276, 21562-21570.
14. Corcoran, K.A., Lu, Y., Turner, R.S. & Maren, S. (2002) Over-expression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease. Learn Mem 9, 243-252.
15. Crabbe, J.C., Wahlsten, D. & Dudek, B.C. (1999) Genetics of mouse behavior: interactions with laboratory environment. Science 284, 1670-1672.
16. Crawley, J.N., Belknap, J.K., Collins, A., Crabbe, J.C., Frankel, W., Henderson, N., Hitzemann, R.J., Maxson, S.C., Miner, L.L., Silva, A.J., Wehner, J.M., Wynshaw-Boris, A. & Paylor, R. (1997) Behavioral phenotypes of inbred mouse strains; implications and recommendations for molecular studies. Psychopharmacology (Berl) 132, 107-124.
17. Diamond, D.M., Park, C.R., Neman, K.L. & Rose, G.M. (1999) Exposing rats to a predator impairs spatial working memory in the radial arm water maze. Hippocampus S, 542-552.
18. Dineley, K.T., Xia, X., Bui, D., Sweatt, J.D. & Zheng, H. (2002) Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. J Biol Chem 277, 22768-22780.
19. Dodart, J.C., Bales, K.R., Gannon, K.S., Greene, S.J., DeMattos, R.B., Mathis, C., DeLong, C.A., Wu, S., Wu, X., Holtzman, D.M. & Paul, S.M. (2002a) Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat Neurosci 5, 452-457.
20. Dodart, J.C., Mathis, C., Bales, K.R. & Paul, S.M. (2002b) Does my mouse have Alzheimer's disease? Genes Brain Behave 1, 142-155.
21. Dodart, J.C., Meziane, H., Mathis, C., Bales, K.R., Paul, S.M. & Ungerer, A. (1999) Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein. Behav Neurosci 113, 982-990.
22. Esler, W.P., Kimberly, W.T., Ostaszewski, B.L., Ye, W., Diehl, T.S., Selkoe, D.J. & Wolfe, M.S. (2002) Activity-dependent isolation of the presenilin-gamma-secretase complex reveals nicastrin and a gamma substrate. Proc Natl Acad Sci USA 99, 2720-2725.
23. Evans, D.A., Funkenstein, H.H., Albert, M.S., Scherr, P.A., Cook, N.R., Chown, M.J., Hebert, L.E., Hennekens, C.H. & Taylor, J.O. (1989) Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 262, 2551-2556.
24. Feany, M.B. & Dickson, D.W. (1996) Neurodegeneratiye disorders with extensive tau pathology: a comparative study and review. Ann Neurol 40, 139-148.
25. Francis, R., McGrath, G., Zhang, J., Ruddy, D.A., Sym, M., Apfeld, J., Nicoll, M., Maxwell, M., Hai, B., Ellis, M.C., Parks, A.L., Xu, W., Li, J., Gurney, M., Myers, R.L., Himes, C.S., Hiebsch, R., Ruble, C., Nye, J.S. & Curtis, D. (2002) aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev Cell 3, 85-97.
26. Fratiglioni, L., Small, B.J., Winblad, B. & Bäckman, L. (2001) The transition from normal functioning to dementia in the ageing population. In Iqbal, K., Sisodia, S. & Winblad, B. (eds), Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics. John Wiley & Sons, Ltd, Chichester, pp. 3-10.
27. Gass, P., Wolfer, D.P., Balschun, D., Rudolph, D., Frey, U., Lipp, H.P. & Schütz, G. (1998) Deficits in memory tasks of mice with CREB mutations depend on gene dosage. Learn Mem 5, 274-288.
28. Gerlai, R., Fitch, T., Bales, K.R. & Gitter, B.D. (2002) Behavioral impairment of APP(V717F) mice in fear conditioning: is it only cognition? Behav Brain Res 136, 503-509.
29. Gordon, M.N., King, D.L., Diamond, D.M., Jantzen, P.T., Boyett, K.V., Hope, C.E., Hatcher, J.M., DiCarlo, G., Gottschall, W.P., Morgan, D. & Arendash, G.W. (2001) Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice. Neurobiol Aging 22, 377-385.
30. Holcomb, L.A., Gordon, M.N., Jantzen, P., Hsiao, K., Duff, K. & Morgan, D. (1999) Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav Genet 29, 177-185.
31. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F.S. & Cole, G. (1996) Correlative memory deficits, a-beta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.
32. Hyde, L.A., Hoplight, B.J. & Denenberg, V.H. (1998) Water version of the radial-arm maze: learning in three inbred strains of mice. Brain Res 785, 236-244.
33. Hyde, L.A., Sherman, G.F., Hoplight, B.J. & Denenberg, V.H. (2000) Working memory deficits in BXSB mice with neocortical ectopias. Physiol Behav 70, 1-5.
34. Janus, C. (2004a) Vaccines for Alzheimer's disease: how close are we? CNS Drugs 17, 457-474.
35. Janus, C. (2004b) Search strategies used by APP transgenic mice during spatial navigation in the Morris water maze. Learn Mem 11, 337-346.
36. Janus, C. & Westaway, D. (2001) Transgenic mouse models of Alzheimer's disease. Physiol Behav 73, 873-886.
37. Janus, C., Chishti, M.A. & Westaway, D. (2000a) Transgenic mouse models of Alzheimer's disease. Biochim Biophys Acta 1502, 63-75.
38. Janus, C., Welzl, H., Hanna, A., Lovasic, L., Lane, N., St George-Hyslop, P. & Westaway, D. (2004) Impaired conditioned taste aversion learning in APP transgenic mice. Neurobiol Aging 25, 1213-1219.
39. Janus, C., Pearson, J., McLaurin, J., Mathews, P.M., Jiang, Y., Schmidt, S.D., Chishti, M.A., Horne, P., Heslin, D., French, J., Mount, H.T.J., Nixon, R.A., Mercken, M., Bergeron, C., Fraser, P.E., St George-Hyslop, P. & Westaway, D. (2000b) A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408, 979-982.
40. Kotilinek, L.A., Bacskai, B., Westerman, M., Kawarabayashi, T., Younkin, L., Hyman, B.T., Younkin, S. & Ashe, K.H. (2002) Reversible memory loss in a mouse transgenic model of Alzheimer's disease. J Neurosci 22, 6331-6335.
41. Lee, V.M., Goedert, M. & Trojanowski, J.Q. (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24, 1121-1159.
42. van Leuven, F. (2000) Single and multiple transgenic mice as models for Alzheimer's disease. Prog Neurobiol 61, 305-312.
43. Locascio, J.J., Growdon, J.H. & Corkin, S. (1995) Cognitive test performance in detecting, staging, and tracking Alzheimer's disease. Arch Neurol 52, 1087-1099.
44. Mandelkow, E.M. & Mandelkow, E. (1998) Tau in Alzheimer's disease. Trends Cell Biol 8, 425-427.
45. Martin, P. & Bateson, P. (1996) Measuring Behaviour. Cambridge University Press, Cambridge.
46. Moechars, D., Dewachter, I., Lorent, K., Reverse, D., Baekelandt, V., Naidu, A., Tesseur, I., Spittaels, K., Haute, C.V., Checler, F., Godaux, E., Cordell, B. & Van Leuven, F. (1999) Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 274, 6483-6492.
47. Morgan, D., Diamond, D.M., Gottschall, P.E., Ugen, K.E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., Connor, K., Hatcher, J., Hope, C., Gordon, M. & Arendash, G.W. (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408, 982-985.
48. Olton, D.S. & Werz, M.A. (1978) Hippocampal function and behavior: spatial discrimination and response inhibition. Physiol Behav 20, 597-605.
49. Price, D.L. & Sisodia, S.S. (1998) Mutant genes in familial Alzheimer's disease and transgenic models. Annu Rev Neurosci 21, 479-505.
50. Price, D.L., Tanzi, R.E., Borcshelt, D.R. & Sisodia, S.S. (1998) Alzheimer's disease: genetic studies and transgenic models. Annu Rev Genet 32, 461-493.
51. Roher, A., Wolfe, D., Palutke, M. & KuKuruga, D. (1986) Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein. Proc Natl Acad Sci USA 83, 2662-2666.
52. Ross, S.M. (2003) Introduction to Probability Models. Academic Press, Inc., San Diego.
53. Seabrook, G.R. & Rosahl, T.W. (1999) Transgenic animals relevant to Alzheimer's disease. Neuropharmacology 38, 1-17.
54. Selkoe, DJ. (1989) Biochemistry of altered brain proteins in Alzheimer's disease. Annu Rev Neurosci 12, 463-490.
55. Selkoe, D.J. (2001) Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 3, 75-80.
56. Small, B.J., Fratiglioni, L., Viitanen, M., Winblad, B. & Backman, L. (2000) The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol 57, 839-844.
57. Steiner, H., Capell, A., Leimer, U. & Haass, C. (1999) Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 249, 266-270.
58. Tanzi, R.E. & Bertram, L. (2001) New frontiers in Alzheimer's disease genetics. Neuron 32, 181-184.
59. Wahlsten, D., Metten, P., Phillips, T.J., Boehm, S.L., II, Burkhart-Kasch, S., Dorow, J., Doerksen, S., Downing, C., Fogarty, J., Rodd-Henricks, K., Hen, R., McKinnon, C.S., Merrill, C.M., Nolte, C., Schalomon, M., Schlumbohm, J.P., Sibert, J.R., Wenger, C.D., Dudek, B.C. & Crabbe, J.C. (2003) Different data from different labs: lessons from studies of gene-environment interaction. J Neurobiol 54, 283-311.
60. Wolfer, D.P., Madani, R., Valenti, P. & Lipp, H.P. (2001) Extended analysis of path data from mutant mice using the public domain software Wintrack. Physiol Behav 73, 745-753.